BAPP AND PRION TRANSFECTED HUMAN MUSCLE CULTURES
BAPP AND PRION TRANSFECTED HUMAN MUSCLE CULTURES
批准号:
2037950
负责人:
VALERIE ASKANAS
金额:
$20.68万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-12-01 至 1998-11-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In this proposal, utilizing infection of cultured human muscle with
BetaAPP or PrPC genes in adenovirus vector, we will pursue the following
aims:
Aim 1. Determine whether long-term overexpression of BetaAPP or PrPc genes
in normal human muscle cultured i) aneurally and ii) innervated, using
adenovirus vector, will induce the IBM-phenotype, including a)
vacuolization and the other aspects of IBM muscle degeneration b) PHFs, c)
congophilic amyloid deposits and d) accumulation of the other IBM-
characteristic proteins.
Aim 2. Determine whether increased ApoE in the muscle fiber (either by
genetic overexpression through an adenovirus vector or by increased
exposure from the culture medium) will facilitate development of the IBM
phenotype in cultured normal human muscle concurrent with Beta APP and/or
PrPc gene overexpression.
Aim 3A. Determine whether challenging cultured h-IBM muscle aneurally or
innervated with extra copies of the BetaAPP or PrPc gene will accelerate
coordinated development in them of the IBM-phenotype and aggravate its
severity, as compared to a) cultured uninfected h-IBM muscle and b) normal
cultured human muscle with concurrently overexpressed BetaAPP and PrPc.
(This is necessary because cultured uninfected h-IBM muscle fibers express
some aspects of the IBM phenotype including increased accumulation of
BetaAPP and PrPc, but this is present only in 20-40% of the muscle fibers
at any given time -the severely affected fibers are dying while others do
not yet express the phenotype).
Aim 3B. Determine whether accumulation of ApoE (either by genetic
expression thru an adenovirus vector or by exposure from the culture
medium) will facilitate development of the IBM phenotype in cultured h-IBM
muscle fibers without and with overexpressed BetaAPP or PrPc in them.
Aim 3C. Determine whether infection of cultured h-IBM with adenovirus
carrying BetaAPP or PrPc cDNA in antisense orientation will inhibit
manifestation of the IBM phenotype.
The broad objectives of our research are to better understand a) molecular
mechanisms leading to increased accumulation in h- and s-IBM of a group of
proteins that are normally not expressed extrajunctionally in adult human
muscle, and b) their role in the disease process.
Our long-term coals are to learn the molecular pathogenic mechanisms
leading to h- and s-IBM which could eventually lead to treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6448889
-
项目类别:
-
资助金额:$25.46万
-
财政年份:2001
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6353435
-
项目类别:
-
资助金额:$25.46万
-
财政年份:2000
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6318249
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2000
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6295391
-
项目类别:
-
资助金额:$33.2万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:2837339
-
项目类别:
-
资助金额:$23.04万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6948644
-
项目类别:
-
资助金额:$1.8万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6884632
-
项目类别:
-
资助金额:$31.28万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6098054
-
项目类别:
-
资助金额:$33.2万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6509651
-
项目类别:
-
资助金额:$33.84万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6294141
-
项目类别:
-
资助金额:$3.2万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6629838
-
项目类别:
-
资助金额:$34.85万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6720867
-
项目类别:
-
资助金额:$31.27万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6372344
-
项目类别:
-
资助金额:$32.88万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6168924
-
项目类别:
-
资助金额:$23.72万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6295383
-
项目类别:
-
资助金额:$33.2万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
BAPP AND PRION TRANSFECTED HUMAN MUSCLE CULTURES
-
批准号:2609681
-
项目类别:
-
资助金额:$26.73万
-
财政年份:1995
-
负责人:VALERIE ASKANAS
-
依托单位:
BAPP AND PRION TRANSFECTED HUMAN MUSCLE CULTURES
-
批准号:2273225
-
项目类别:
-
资助金额:$19.86万
-
财政年份:1995
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER BETA-AMYLOID PROTEIN IN DISEASED HUMAN MUSCLE
-
批准号:2269793
-
项目类别:
-
资助金额:$6.88万
-
财政年份:1993
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER BETA-AMYLOID PROTEIN IN DISEASED HUMAN MUSCLE
-
批准号:2269794
-
项目类别:
-
资助金额:$7.19万
-
财政年份:1993
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER BETA-AMYLOID PROTEIN IN DISEASED HUMAN MUSCLE
-
批准号:3418751
-
项目类别:
-
资助金额:$6.6万
-
财政年份:1993
-
负责人:VALERIE ASKANAS
-
依托单位:
海外基金